Cartesian Therapeutics Inc header image

Cartesian Therapeutics Inc

RNAC

Equity

ISIN null / Valor 134256445

NASDAQ (2026-03-03)
USD 7.48-1.58%

Cartesian Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cartesian Therapeutics Inc. is a biotechnology company specializing in the development of RNA cell therapies for autoimmune, oncologic, and respiratory diseases. The company leverages its proprietary RNA Armory platform to engineer cell therapies that can be precisely controlled and directed to target specific disease mechanisms. Cartesian's lead product candidates include Descartes-08, an RNA-engineered cell therapy for myasthenia gravis, and Descartes-11, aimed at treating multiple myeloma. The company is focused on advancing these therapies through clinical trials to address unmet medical needs in these complex conditions.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-57.3%1Y
-83.9%3Y
-93.8%5Y

Performance

82.0%1Y
93.6%3Y
88.0%5Y

Volatility

Market cap

195 M

Market cap (USD)

Daily traded volume (Shares)

66,289

Daily traded volume (Shares)

1 day high/low

19.47 / 18.13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Worldline SA
Worldline SA Worldline SA Valor: 24715654
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-11.55%EUR 1.46
Nexans
Nexans Nexans Valor: 1242479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.81%EUR 116.70
Atos SE
Atos SE Atos SE Valor: 167932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.66%EUR 37.95
Neurones
Neurones Neurones Valor: 837153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.46%EUR 33.85
Tietoevry Oyj
Tietoevry Oyj Tietoevry Oyj Valor: 472478
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.30%EUR 18.19
Revenio Group Oyj
Revenio Group Oyj Revenio Group Oyj Valor: 1304192
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%EUR 17.90
SAP SE
SAP SE SAP SE Valor: 345952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%EUR 165.48
Rational AG
Rational AG Rational AG Valor: 635626
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.26%EUR 715.00
SMA Solar Technology AG
SMA Solar Technology AG SMA Solar Technology AG Valor: 4337414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.34%EUR 29.16
Siltronic AG
Siltronic AG Siltronic AG Valor: 28423342
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.80%EUR 53.10